# Clinical trials recruiting in Philippines: 91 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 91 trials recruiting or not yet recruiting with a site in Philippines, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Philippines: 91 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/country/philippines

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 91
- Recruiting or not yet: 91
- Read on: November 19, 2026

## Trials

The 25 newest of 91, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 4, 2026 | NCT07915219 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Bronchiectasis | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915219) |
| November 2, 2026 | NCT07909044 | Training, Coaching and Marketing Program for Vegetable and Fruit Vendors in Markets to Improve Food Safety Practices and Vegetable and... | The International Livestock Research Institute (ILRI) | Not applicable | Recruiting | Intake of Fruit, Intake of Vegetables, Food Safety | 1,143 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07909044) |
| October 6, 2026 | NCT07861997 | ENRICH Study: A Mixed-methods Feasibility Study of a Nurse-led Model of Care for Social Frailty in Philippine Primary Care | The Hong Kong Polytechnic University | Not applicable | Not yet recruiting | Frailty, Frailty in Older Adults, Frailty in Aging | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07861997) |
| October 1, 2026 | NCT07851025 | Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced... | AstraZeneca | Phase 3 | Recruiting | Epithelial Ovarian Cancer | 950 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07851025) |
| September 23, 2026 | NCT07837336 | An Evaluation of Nutritional Status, Body Composition, and Dietary Intakes of Filipino Pediatric Patients With Inborn Errors of... | Food and Nutrition Research Institute, Philippines | Observational | Recruiting | Metabolism, Inborn Errors, Amino Acid Metabolism, Inborn Errors | 176 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07837336) |
| August 20, 2026 | NCT07775404 | A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2... | AstraZeneca | Phase 3 | Recruiting | Obesity, Overweight | 351 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07775404) |
| August 10, 2026 | NCT07753993 | A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease. | AstraZeneca | Phase 3 | Recruiting | Chronic Kidney Disease | 7,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07753993) |
| July 9, 2026 | NCT07691970 | Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From... | AstraZeneca | Phase 3 | Recruiting | Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus | 1,072 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07691970) |
| June 5, 2026 | NCT07630714 | A Study to Investigate Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Anifrolumab in Pediatric Participants 5 to \< 18 Years... | AstraZeneca | Phase 2 | Recruiting | Systemic Lupus Erythematosus | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07630714) |
| June 5, 2026 | NCT07630584 | Growth, Tolerance, and Functional Biomarkers in Healthy Infants Receiving Dietary Supplements | Société des Produits Nestlé (SPN) | Not applicable | Recruiting | Healthy Infants | 327 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07630584) |
| June 3, 2026 | NCT07624305 | A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD) | AstraZeneca | Phase 3 | Recruiting | Renal Insufficiency, Chronic | 2,800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07624305) |
| May 19, 2026 | NCT07595432 | The Purpose of This Clinical Study is to Evaluate Optimized Maximum Plus for Maximum Visual Acuity (MPMVA) Refractive Technique and Its... | Hoya Surgical Optics, Inc. | Observational | Recruiting | Visual Outcome | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07595432) |
| May 19, 2026 | NCT07595042 | A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB) | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 | Not yet recruiting | Tuberculosis | 900 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07595042) |
| May 18, 2026 | NCT07593924 | Clinical Trial of PCV13 in Infants Aged Approximately 2 Months (42 to 89 Days) | Sinovac Life Sciences Co., Ltd. | Phase 3 | Not yet recruiting | Pneumococcal Infectious Diseases | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07593924) |
| May 14, 2026 | NCT07587138 | Clinical Evaluation of a Novel Trifocal IOL | Alcon Research | Not applicable | Recruiting | Aphakia, Cataract | 66 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07587138) |
| May 1, 2026 | NCT07562347 | Clinical Experience and Real-world Safety and Effectiveness of Envafolimab: Patient Access Program | IR INNOVATE RESEARCH PRIVATE LIMITED | Observational | Recruiting | Advanced Solid Tumor | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07562347) |
| April 21, 2026 | NCT07543458 | Therapeutics for Moderate and Severe Dengue | Oxford University Clinical Research Unit, Vietnam | Phase 3 | Not yet recruiting | Dengue, Severe Dengue, Mosquito-Borne Diseases, Vector Borne Diseases, Arbovirus Infections, Flavivirus Infections, RNA... | 8,800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07543458) |
| April 20, 2026 | NCT07540793 | Evaluation of 7-day vs 1-day Packaging of Small Quantity Lipid-based Nutrition Supplementation (SQ-LNS) | University of California, San Francisco | Not applicable | Not yet recruiting | Prevention, Malnutrition, Child, Nutrition | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07540793) |
| April 16, 2026 | NCT07532863 | A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Participants | Novo Nordisk A/S | Observational | Recruiting | Diabetes Mellitus, Type 2 | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07532863) |
| March 27, 2026 | NCT07497087 | A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis | Boehringer Ingelheim | Phase 3 | Recruiting | Systemic Sclerosis | 448 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07497087) |
| March 12, 2026 | NCT07468409 | JASPER™ Robotic Surgical System (Formerly Known as the ORYOM™ Robotic Surgical System) in Cataract Surgery | ForSight Robotics Ltd | Not applicable | Recruiting | Cataract | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07468409) |
| March 12, 2026 | NCT07467707 | An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease in Adolescents and Adults | Bavarian Nordic | Phase 3 | Recruiting | Chikungunya Virus | 6,144 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07467707) |
| March 9, 2026 | NCT07457060 | Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine | Sinovac Biotech Co., Ltd | Phase 4 | Recruiting | Poliomyelitis | 480 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07457060) |
| February 17, 2026 | NCT07415252 | SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years | SK Bioscience Co., Ltd. | Phase 3 | Recruiting | Varicella (Chickenpox) | 780 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07415252) |
| February 2, 2026 | NCT07382401 | Developing Immersive Gamification Technology Systems For The Rehabilitation Management Of Adults With Parkinson's Disease (Phase 1 Trial) | Augmented eXperience E-health Laboratory | Not applicable | Not yet recruiting | Parkinson Disease, Parkinson&#39;s Disease (PD) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07382401) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Manila Doctors Hospital | Manila | 7 |
| Philippine General Hospital | Manila | 7 |
| Mary Mediatrix Medical Center | Lipa | 5 |
| The Medical City | Pasig | 5 |
| Perpetual Succour Hospital | Cebu City | 3 |
| Makati Medical Center | Makati City | 3 |
| Asian Eye Institute | Makati City | 3 |
| Health Cube Medical Clinics | Mandaluyong | 3 |
| Davao Doctors Hospital | Davao City | 2 |
| Cardinal Santos Medical Center | San Juan City | 2 |
| Silang Specialist Medical Center | Silang | 2 |
| Tropical Disease Foundation | Makati City | 2 |
| St. Luke's Medical Center | Quezon City | 2 |
| De La Salle Medical and Health Sciences Institute | Dasmariñas | 2 |
| San Lazaro Hospital | Manila | 2 |
| University of Santo Tomas | Manila | 2 |
| University of the Philippines | Quezon City | 2 |
| Iloilo Doctors Hospital | Iloilo City | 2 |
| West Visayas State University Medical Center | Iloilo City | 2 |
| Quirino Memorial Medical Center | Quezon City | 2 |
| THE MEDICAL CITY ILOILO | Iloilo City | 1 |
| St. Lukes Medical Center Global City | City of Taguig | 1 |
| CARE Clinical Trial Group | Dasmariñas | 1 |
| Manila Med Medical Centre Manila | Manila | 1 |
| Institute for Studies on Diabetes Foundation Inc. | Marikina City | 1 |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 1 |
| Phase 1/2 | 1 |
| Phase 2 | 7 |
| Phase 2/3 | 2 |
| Phase 3 | 46 |
| Phase 4 | 1 |
| Not applicable | 17 |
| Observational | 16 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Parkinson Disease 4, Autosomal Dominant Lewy Body | 5 |
| Breast Neoplasms | 5 |
| Renal Insufficiency, Chronic | 5 |
| Diabetes Mellitus, Type 2 | 4 |
| Hypertension | 4 |
| Tuberculosis | 4 |
| Cardiovascular Diseases | 3 |
| COVID-19 | 3 |
| Asthma | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Cataract | 3 |
| Triple Negative Breast Neoplasms | 2 |
| Coronavirus Infections | 2 |
| HIV Infections | 2 |
| Wounds and Injuries | 2 |
| Lung Diseases | 2 |
| Pulmonary Disease, Chronic Obstructive | 2 |
| Hematologic Neoplasms | 2 |
| Kidney Diseases | 2 |
| Lupus Erythematosus, Systemic | 2 |
| Bronchiectasis | 2 |
| Child Nutrition Disorders | 2 |
| Heart Failure | 2 |
| Tuberculosis, Multidrug-Resistant | 1 |
| Carcinoma, Squamous Cell | 1 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 21 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 8 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 5 |
| [Société des Produits Nestlé (SPN)](https://specstream.ai/data/clinical-trials/company/soci-t-des-produits-nestl-spn) | 3 |
| University of California, San Francisco | 3 |
| [Genzyme, a Sanofi Company](https://specstream.ai/data/clinical-trials/company/genzyme-a-sanofi-company) | 3 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| University of the Philippines | 2 |
| [Alcon Research](https://specstream.ai/data/clinical-trials/company/alcon-research) | 2 |
| [Otsuka Pharmaceutical Development & Commercialization, Inc.](https://specstream.ai/data/clinical-trials/company/otsuka-pharmaceutical-development-and-commercialization-inc) | 1 |
| Gylden Pharma Ltd | 1 |
| Johnson & Johnson Enterprise Innovation Inc. | 1 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 1 |
| Medicines Development for Global Health | 1 |
| Urovant Sciences GmbH | 1 |
| Henry M. Jackson Foundation for the Advancement of Military Medicine | 1 |
| [Sinovac Biotech Co., Ltd](https://specstream.ai/data/clinical-trials/company/sinovac-biotech-co-ltd) | 1 |
| National Kidney and Transplant Institute, Philippines | 1 |
| [Sinovac Life Sciences Co., Ltd.](https://specstream.ai/data/clinical-trials/company/sinovac-life-sciences-co-ltd) | 1 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 1 |
| Hoya Surgical Optics, Inc. | 1 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 1 |
| Dianthus Therapeutics | 1 |
| National University Health System, Singapore | 1 |
| Makati Medical Center | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Media agencies in the United States](https://specstream.ai/data/businesses/media-agencies/united-states)
- [B2B oil and gas exploration and development companies in the United States](https://specstream.ai/data/businesses/b2b-oil-and-gas-exploration-and-development-companies/united-states)
- [Marketing agencies in the United States](https://specstream.ai/data/businesses/marketing-agencies/united-states)
- [B2B international trade companies in the United States](https://specstream.ai/data/businesses/b2b-international-trade-companies/united-states)
- [Lumber stores in the United States](https://specstream.ai/data/businesses/lumber-stores/united-states)
- [B2B direct mail advertising companies in the United States](https://specstream.ai/data/businesses/b2b-direct-mail-advertising-companies/united-states)
